David Shook Lyell Immunopharma, Inc. (LYEL) insider trading activity
David Shook is Chief Medical Officer of Lyell Immunopharma, Inc.. Currently has a direct ownership of 21,900 shares of LYEL, which is worth approximately $212,211. The most recent transaction as insider was on Jun 09, 2025, when has been sold 21,900 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
21.9K
n/a
3M change
n/a
12M change
Total Value Held
$212,211
David Shook Transaction History
Also insider at
DS
David Shook
Chief Medical Officer
South San Francisco, CA